DNA Products

Carlsbad, CA: (Feb-6-08) Invitrogen Corporation brought charges against Agilent Technologies, over patent infringement issues. Records state that the two companies have been embroiled in multiple patent litigation since 2001. Sources close to the case stated that the companies reached a settlement, resolving three patent infringement lawsuits between Invitrogen and Stratagene, Inc. Agilent acquired Stratagene in 2007. Sources claim that patent litigation between the companies had been pending since 2000 and 2001.

In June 2000, Invitrogen sued Stratagene in the United States District Court for the District of Maryland, Southern Division, for infringement of patents relating to the use and sale of RNase H minus reverse transcriptase products. This case had been pending resolution of a related litigation with Clontech. Under the terms of the agreement, Agilent will make an undisclosed settlement payment to Invitrogen. In addition, Agilent will discontinue sales of its RNase H minus RT products and Invitrogen will obtain a license from Agilent and pay an undisclosed royalty to sell its DNA polymerase blend products. Due to a confidentiality clause, no details of the deal will be disclosed. [FOX BUSINESS: DNA PRODUCT PATENT]

Legal Help

If you have a similar problem and would like to be contacted by a lawyer at no cost or obligation, please click the link below.

Please click here for a free evaluation of your claim

Published on Feb-7-08